SynthesisEuropean journal of clinical pharmacology2023

Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials.

Mengnan Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.